Inspire Medical Systems, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
MINNEAPOLIS, May 30, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the Goldman Sachs 39th Annual Global Healthcare Conference on June 12, 2018 at the Terranea Resort in Rancho Palos Verdes, California.
Inspire is scheduled to present at 10:00 a.m. Pacific Time. The presentation will be accessible via a live webcast, accessible at: https://cc.talkpoint.com/gold006/061218a_as/?entity=59_O7M1CJB
A webcast replay of the presentation will be available on the Investor section of Inspire’s website at www.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire Medical Systems’ proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For more information, please visit www.inspiresleep.com.
Inspire Investor Relations Contact
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
